Table 1. Clinical characteristics of the study subjects (N = 219).
Age (year) | 52.0 (46.0, 59.0) |
Left breast cancer | 112 (51.1%) |
Right breast cancer | 107 (48.9%) |
Max diameter of cancer (cm) | 2.2 (1.5, 3.0) |
Invasive lobular carcinoma | 9 (4.1%) |
Invasive ductal carcinoma | 210 (95.9%) |
Axillary lymph node metastasis | 91 (41.6%) |
ER+ | 147 (67.1%) |
PR+ | 143 (65.3%) |
HER-2+ | 52 (23.7%) |
Ki67 | 30.0% (15.0%, 50.0%) |
Luminal A | 39 (17.8%) |
Luminal B | 95 (43.4%) |
HER-2 overexpression | 53 (24.2%) |
ER-, PR- and Her-2- | 32 (14.6%) |
Abbreviations: Continuous variables are presented as median (with interquartile range); categorical variables are presented as number (percentage). ER+, estrogen receptor positive; PR+, progesterone receptor positive; HER-2+, human epidermal growth factor receptor-2 positive; Ki67, Ki67 nuclear antigen.